Given the central regulatory function of SLC3A2 and the increasing interest in plant-derived anti-cancer agents, exploring the binding potential of ginsenosides to SLC3A2 may provide new insights into natural ligand-based inhibition of amino acid transporters in cancer. The gene discussed is SLC38A7; the disease is cancer.